Anxiety and Related Sleep Disorders - Nigeria

Revenue in the Anxiety and Related Sleep Disorders market is projected to reach US$20.56m in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of -45.46%, resulting in a market volume of US$992.30k by 2029.
In global comparison, most revenue will be generated United States (US$3.21bn in 2024).
In relation to total population figures, per person revenues of US$2.45 are generated in 2024.

The Anxiety and Related Sleep Disorders market covers sales of three drug classes: anxiolytics, hypnotics, and sedatives. These classes contain different types of drugs, such as benzodiazepines, anticonvulsants, and antihistamines, that reduce anxiety and insomnia symptoms caused by anxiety. These medications mainly fall into the category of prescription drugs.

Market values represent the revenues generated by manufacturers and are based on retail prices for each drug category including all drugs, regardless of whether they are reimbursed or not.

Company examples: Pfizer, Bristol-Myers Squibb, GlaxoSmithKline PLC, Johnson & Johnson, and Merck & Co.

Pharmaceutical sales and consumption of anxiolytics
Pharmaceutical sales and consumption hypnotics and sedatives

Non-mental health related sleep disorders
Any other anxiety medications
Psychotherapy

The Anxiety and Related Sleep Disorders market in Nigeria is experiencing significant growth due to several factors.

Customer preferences: Customers in Nigeria are increasingly seeking solutions for anxiety and related sleep disorders. This can be attributed to the rising awareness and understanding of mental health issues in the country. As more individuals recognize the impact of anxiety and sleep disorders on their overall well-being, they are actively seeking products and services that can help alleviate these conditions. Additionally, the younger generation in Nigeria, who are more open to discussing mental health, are driving the demand for anxiety and sleep disorder treatments.

Trends in the market: One of the key trends in the Anxiety and Related Sleep Disorders market in Nigeria is the growing popularity of natural and holistic remedies. Many customers are turning to herbal supplements, meditation, and relaxation techniques as alternative or complementary treatments for anxiety and sleep disorders. This trend is fueled by the desire for more sustainable and non-invasive solutions. Additionally, there is an increasing demand for personalized treatment options, as customers recognize that anxiety and sleep disorders can vary greatly from person to person.

Local special circumstances: Nigeria has a large and growing population, which presents both opportunities and challenges for the Anxiety and Related Sleep Disorders market. On one hand, the large customer base provides a significant market potential. On the other hand, the fragmented healthcare system and limited access to mental health services pose challenges in reaching and treating a wide range of customers. However, the increasing presence of online platforms and telemedicine services in Nigeria is helping to bridge this gap by providing easier access to information and treatment options.

Underlying macroeconomic factors: The economic growth and increasing disposable income in Nigeria are contributing to the development of the Anxiety and Related Sleep Disorders market. As people's lifestyles become more hectic and stressful, the demand for anxiety and sleep disorder treatments is expected to rise. Additionally, the growing middle class in Nigeria has more purchasing power and is willing to invest in their mental well-being. This provides a favorable environment for the market to thrive.In conclusion, the Anxiety and Related Sleep Disorders market in Nigeria is witnessing significant growth driven by increasing customer awareness and preferences, the popularity of natural remedies, and the country's economic development. Despite the challenges posed by the healthcare system, the market is expected to continue expanding as more individuals prioritize their mental health and seek effective solutions for anxiety and sleep disorders.

Data coverage:

Data encompasses B2C enterprises. Figures are based on companies' revenues, international institutes data, and global consumer survey data. Revenues refer to the retail value and include sales taxes.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use financial reports and third-party data. Next, we use relevant key market indicators and data from country-specific associations such as healthcare spending per capita, medical product spending per capita, and gross domestic product per capita. This data helps us to estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, S-Curve function, ARIMA time series model and exponential curve function. Data is modeled using current exchange rates.

Additional Notes:

The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. GCS data is reweighted for representativeness.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

Despite what some may think, mental health problems are common in the United States and around the world. Mental health issues, much like other health issues, can be mild, but can also be life altering, affecting the emotional, social, and psychological well-being of the person. Common types of mental illness include mood disorders, anxiety disorders, eating disorders, and personality disorders. Although symptoms of mental illness differ depending on the type of illness and seriousness of the problem, common symptoms of mental health issues include changes in sleeping and eating habits, social withdrawal, feelings of hopelessness, anger, and prolonged sadness, suicidal thoughts, and substance abuse. In 2022, it was estimated that around 36 percent of those in the U.S. aged 18 to 25 years and 29 percent of those aged 26 to 49 years suffered from some form of mental illness in the past year.